Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study
- PMID: 35859543
- PMCID: PMC9290893
- DOI: 10.1093/nop/npac026
Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study
Abstract
Background: Glioblastoma (GBM) carries a poor prognosis despite standard of care. Early palliative care (PC) has been shown to enhance survival and quality of life while reducing healthcare costs for other cancers. This study investigates differences in PC timing on outcomes for patients with GBM.
Methods: This study used Surveillance, Epidemiology, and End Results (SEER)-Medicare data from 1997 to 2016. Based on ICD codes, three groups were defined: (1) early PC within 10 weeks of diagnosis, (2) late PC, and (3) no PC. Outcomes were compared between the three groups.
Results: Out of 10 812 patients with GBM, 1648 (15.24%) patients had PC consultation with an overall positive trend over time. There were no significant differences in patient characteristics. The late PC group had significantly higher number of hospice claims (1.06 ± 0.69) compared to those without PC, in the last month of life. There were significant differences in survival among the three groups (P < .0001), with late PC patients with the longest mean time to death from diagnosis (11.72 ± 13.20 months).
Conclusion: We present the first investigation of PC consultation prevalence and outcomes, stratified by early versus late timing, for adult GBM patients. Despite an overall increase in PC consultations, only a minority of GBM patients receive PC. Patients with late PC had the longest survival times and had greater hospice use in the last month of life compared to other subgroups. Prospective studies can provide additional valuable information about this unique population of patients with GBM.
Keywords: glioblastoma; healthcare costs; hospice; palliative care; resource utilization.
Published by Oxford University Press 2022.
Figures



Similar articles
-
The Magnitude and Effects of Early Integration of Palliative Care Into Oncology Service Among Adult Advanced Cancer Patients at a Tertiary Care Hospital.Cureus. 2021 May 29;13(5):e15313. doi: 10.7759/cureus.15313. Cureus. 2021. PMID: 34211813 Free PMC article.
-
Timing of Palliative Care Consultation Impacts End of Life Care Outcomes in Metastatic Non-Small Cell Lung Cancer.J Pain Symptom Manage. 2024 Oct;68(4):e325-e332. doi: 10.1016/j.jpainsymman.2024.07.008. Epub 2024 Jul 24. J Pain Symptom Manage. 2024. PMID: 39002711
-
Hospice and palliative care utilization in 16 004 232 medicare claims: comparing trauma to surgical and medical inpatients.Trauma Surg Acute Care Open. 2024 Apr 17;9(1):e001329. doi: 10.1136/tsaco-2023-001329. eCollection 2024. Trauma Surg Acute Care Open. 2024. PMID: 38646618 Free PMC article.
-
Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review.Cancers (Basel). 2021 Jun 8;13(12):2867. doi: 10.3390/cancers13122867. Cancers (Basel). 2021. PMID: 34201260 Free PMC article. Review.
-
End-of-Life Care, Palliative Care Consultation, and Palliative Care Referral in the Emergency Department: A Systematic Review.J Pain Symptom Manage. 2020 Feb;59(2):372-383.e1. doi: 10.1016/j.jpainsymman.2019.09.020. Epub 2019 Oct 3. J Pain Symptom Manage. 2020. PMID: 31586580
Cited by
-
Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma.Neurooncol Pract. 2024 Mar 14;11(4):404-412. doi: 10.1093/nop/npae022. eCollection 2024 Aug. Neurooncol Pract. 2024. PMID: 39006519 Free PMC article.
-
Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery.Cancers (Basel). 2023 Feb 2;15(3):940. doi: 10.3390/cancers15030940. Cancers (Basel). 2023. PMID: 36765898 Free PMC article. Review.
-
Benchmarking palliative care practices in neurooncology: a german perspective.J Neurooncol. 2024 Jun;168(2):333-343. doi: 10.1007/s11060-024-04674-7. Epub 2024 May 2. J Neurooncol. 2024. PMID: 38696050 Free PMC article.
-
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.J Neurooncol. 2023 Jun;163(2):339-344. doi: 10.1007/s11060-023-04342-2. Epub 2023 May 25. J Neurooncol. 2023. PMID: 37227648 Free PMC article.
-
"Life…Gets Turned Upside-Down…" Opportunities to Improve Palliative Care for High-Grade Glioma.J Pain Symptom Manage. 2024 Sep;68(3):272-281.e2. doi: 10.1016/j.jpainsymman.2024.06.001. Epub 2024 Jun 10. J Pain Symptom Manage. 2024. PMID: 38866115 Free PMC article.
References
-
- Stupp R, Taillibert S, Kanner AA, et al. . Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314(23):2535–2543. - PubMed
-
- Nabors LB, Portnow J, Ahluwalia M, et al. . Central nervous system cancers, version 3.2020. JNCCN J Natl Compr Cancer Netw. 2020;18(11):1537–1570. - PubMed
-
- Palliative Care. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/palliative-care. Accessed April 5, 2022.
-
- Holmenlund K, Sjogren P, Nordly M. Specialized palliative care in advanced cancer: What is the efficacy? A systematic review. Palliat Support Care. 2017;15(6):724–740. - PubMed